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Abstract. To assess the changing role of cardiac cath-
eterization in the care of the neonate, a retrospective
review of all catheterizations between January 1984 to
December 1985 (group I) and January 1994 to December
1995 (group II) at C.S. Mott Children’s Hospital was
performed. Neonatal cardiac catheterization was per-
formed more frequently (p 4 0.02) in group I, compris-
ing 14% (110 of 772) of all catheterizations versus 11%
(93 of 880) in group II. Access was performed by cut-
down in 15 patients (13 venous and 2 arterial), all in
group I. In group I, 20 of 110 patients (18%) had balloon
atrial septostomies; no other catheter interventions were
performed. Interventions were more frequent (p 4
0.003) and varied in group II, including 15 septostomies,
17 balloon valvuloplasties (13 pulmonary and 4 aortic), 2
coil embolizations of collaterals, and 1 cardiac biopsy.
Despite the higher prevalence and complexity of inter-
ventions in group II, fluoroscopy times (median; range:
16 min; 2–55 vs 16 min; 1–107) were similar in both
groups (p 4 not significant) as well as the prevalence of
complications. Neonatal cardiac catheterizations are per-
formed less frequently than they were a decade ago at our
institution, and therapeutic interventions have become
more common. Despite these changes, fluoroscopy time
and the rate of complications have not increased.
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Cardiac catheterization in the neonate has been an im-
portant diagnostic tool for several decades. However,
since the advent of two-dimensional echocardiography
and color-flow Doppler, cardiac catheterization is less
frequently essential for anatomic and hemodynamic di-
agnosis. Concurrently, the introduction of lower profile
catheters and intravascular devices brought transcatheter
therapies to the neonate as diagnostic catheterization was
replaced by echocardiography. To evaluate these rapidly
changing practices in pediatric cardiology, we review our
experience with neonatal cardiac catheterizations during
a period of 10 years at a single institution.
Methods
A retrospective review of all cardiac catheterizations performed from
January 1984 through December 1985 (group I) and January 1994
through December 1995 (group II) at C.S. Mott Children’s Hospital
was performed. Inclusion criteria for the study included all neonates
(ø28 days) who underwent cardiac catheterization and excluded those
who entered the catheterization laboratory for other procedures. Cath-
eterization reports were reviewed to determine age and weight at the
time of the procedure. Cardiac catheterization quality assurance forms
completed by the catheterization clinical nurse specialist were reviewed
to assess complications. Method of vascular access, indication for cath-
eterization, fluoroscopy times, and complications were also noted. All
values are expressed as median with ranges. Categorical variables were
compared by contingency analysis and continuous variables by analysis
of variance.
Results
There were 772 cardiac catheterization procedures in
1984 and 1985, of which 110 neonatal procedures (14%)
were performed in group I. This proportion was signifi-
cantly (p 4 0.02) higher than the 93 neonatal procedures
in group II, which represented 11% of the 880 total cath-
eterizations. Neonatal catheterization was performed at
an earlier age (p 4 0.02) in group I; however, weights
were similar (p 4 not significant [NS]) in both groups
(Table 1). The diagnoses in each group are listed in Ta-
ble 2.
Vascular access was achieved by cutdown in 15 pa-
tients in group I, with 11 patients who required cutdown
for venous access, 2 patients for arterial access, and two
patients who required cutdown for both venous and ar-
terial access. In contrast, no patient in group II under-
went cutdown for vascular access (p < 0.001), althoughCorrespondence to:D. Shim
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catheterization was aborted in 1 patient due to lack of
access and 3 patients underwent catheterization via the
transhepatic venous approach.
Cardiac catheterization was performed for primarily
diagnostic purposes in all 110 neonates in group I. In
contrast, 58 of 93 neonates (62%) in group II underwent
diagnostic catheterization (p < 0.001). As indicated in
Table 2, anomalous pulmonary venous return, coarcta-
tion of the aorta, and truncus arteriosus were common
indications for diagnostic cardiac catheterization in 1984
and 1985, but these require catheterization less fre-
quently in contemporary practice. Transcatheter therapy
was more often the indication for cardiac catheterization
in group II compared with group I. The proportion of
neonatal cardiac interventions was significantly different
between the two study periods (p 4 0.003) with thera-
peutic catheterizations comprising 20 of 110 (18%) neo-
natal catheterizations in 1984 and 1985, consisting ex-
clusively of balloon atrial septostomies; in all these neo-
nates catheterization was also performed to obtain
diagnostic data. However, in 1994 and 1995, therapeutic
procedures were performed in 35 of 93 (38%) neonates,
including balloon atrial septostomies (n 4 15) as well as
pulmonary balloon valvuloplasties (n 4 13), aortic bal-
loon valvuloplasties (n 4 4), coil embolization of col-
laterals (n 4 2), and endomyocardial biopsy (n 4 1).
Despite the higher prevalence and complexity of in-
terventions performed in group II, the rate of complica-
tions was similar to that of group I (p 4 NS; Table 3). Of
note is the high incidence of vascular complications in
group I, including absent or decreased femoral pulse (n
4 17) and venostasis (n 4 5), in comparison to group II,
which had no reported instances of vascular complica-
tions. The incidence of blood transfusions was signifi-
cantly higher in group I (p < 0.001) with 83 (75% of
patients) transfusions performed, with only 3 associated
with hypotension and 2 with excessive bleeding. In con-
trast, transfusions were performed in 23 patients (35%)
in group II for hypotension (n 4 3), perforation of the
right ventricular outflow tract during pulmonary valvu-
lopasty (n 4 2), dissection with tamponade (n 4 2), and
excessive blood loss (n 4 1). Fluoroscopy times (16
min; 2–55 vs 16 min; 1–107) did not differ between the
groups (p 4 NS).
Discussion
The data presented herein document the rapid changes
that have occurred in the practice of neonatal cardiology
Table 1.Comparison of ages and weights of groups I and II
Parameter Group I Group II p
Age (median; range) 3 days; 1–28 days 6 days; 1–28 days 0.02
Weight (median;
range) 3.3 kg; 1.2–4.7 kg 3.2 kg; 1.6–4.6 kg NS
NS, not significant.
Table 2.Cardiac diagnoses of groups I and II
Diagnosis Group I Group II
Aortic stenosis 2 5 (4)a
Anomalous left coronary artery 0 2
Anomalous pulmonary venous return 8 3 (1)a
Arteriovenous malformations 1 0
Cardiomyopathy 1 2 (1)a
Coarctation of the aorta 25 4
Discontinuous pulmonary arteries 0 1
Double-inlet left ventricle 2 4
Double-outlet right ventricle 4 3
Double-outlet left ventricle 0 1
Ebstein’s anomaly 0 1
Endocardial cushion defect 4 5 (1)a
Hypoplastic left heart syndrome 7 (1)b 7 (1)a,b
Persistant fetal circulation 4 0
Pulmonary atresia/ventricular septal defect 2 9
Pulmonary atresia/intact ventricular septum 6 (2)b 4
Pulmonary stenosis 6 13a
Supraventricular tachycardia 2 0
Tetralogy of Fallot 4 9 (1)a,b
D-transposition of the great arteries 17 (15)b 16 (12)a,b
L-transposition of the great arteries 5 (1)b 0
Tricuspid atresia 3 (1)b 1 (1)a,b
Truncus arteriosus 5 2
Ventricular septal defect 2 1
Total 110 93
a Numbers in parentheses indicate the numbers of patients in which the
therapeutic catheterization procedure was performed.
b Numbers in parentheses indicate the numbers of patients in which
balloon atrial septostomy was performed.
Table 3.Complications encountered during neonatal cardiac catheter-
izations from January 1984 to December 1985 (group I) and January
1994 to December 1995 (group II)
Complications Group I Group II
Cardiopulmonary resuscitation 4 3
Death 2 0
Dissection with tamponade 1 1
Embolization of guidewire fragment 0 1
Electrophysiologic events 37 13
Hypercyanotic spell 1 3
Hypotension 1 6
Hypothermia 2 0
Perforation of right ventricular
outflow tract 0 4
Respiratory distress 3 1
Stain 1 1
Vascular complications 24 7
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during the past decade. The indications for neonatal car-
diac catheterization, associated with increased death and
morbidity [1], have shifted from predominately diagnos-
tic to a nearly equal mix of diagnostic and therapeutic
procedures. Advances in echocardiography have largely
eliminated the need for diagnostic catheterization studies
in neonates with anomalous pulmonary venous return,
coarctation of the aorta, and truncus arteriosus. The de-
creased need for diagnostic catheterization for coarcta-
tion of the aorta became more evident in 1987 as de-
scribed by George et al. [2]. However, therapeutic cath-
eterization procedures for the neonate with critical
pulmonary or aortic stenosis, which were not available in
1984, are now commonplace. Thus, the care of neonatal
heart disease has become substantially less invasive in
the past decade, with a shift in diagnosis from the cath-
eterization laboratory to the echocardiogram suite and a
concomitant shift in some therapies from the operating
room to the catheterization laboratory.
In addition to the changing indications for neonatal
cardiac catheterization, our data also show that neonatal
catheterizations currently comprise a smaller proportion
of pediatric catheterizations than in the previous decade
(14% vs 17%;p 4 0.02). This comparison is likely to be
confounded by changing indications for cardiac catheter-
izations beyond the neonatal period. When the number of
pediatric open heart operations is used as a more consis-
tent basis comparison, the decrease in neonatal cardiac
catheterizations is even more dramatic, decreasing from
one case per 2.50 pediatric open hearts in 1984 to one
case per 10.04 open hearts in 1994 (p < 0.0001). Thus,
although the raw number of neonatal catheterizations has
remained essentially unchanged, they have become less
common as the pediatric cardiology program at our cen-
ter has grown when compared to total number of cardiac
catheterizations and pediatric open heart surgeries.
Transfusions were more prevalent in group I com-
pared to group II (75% vs 35%) which may reflect more
judicious use of transfusions in the era of increased
awareness of HIV. The use of blood transfusions has
become more reserved for specific indications, especially
those related to complications as a direct result of cath-
eterization rather than for palliation of a cyanotic new-
born with low hematocrit. Transfusions in response to
complications comprise a greater proportion (8 of 23;
35%) of transfusions in group II compared to group I (5
of 83; 6%).
Other noteworthy patterns revealed by these data
relate to catheterization complications and vascular ac-
cess. Despite the increase in number of therapeutic car-
diac catheterizations in recent years, the complication
rate has not increased (Table 3). This may reflect the
current availability of smaller catheters, improved tech-
niques (e.g., monitoring heparinization by activated clot-
ting times [3]), and patient selection. The lower inci-
dence of vascular complications, such as absent or de-
creased femoral pulse and venostasis in group II,
supports these observations. Similar decreases in vascu-
lar complications were also described by Cassidyet al.
[1]. Transient heart block remains the most common
complication of neonatal cardiac catheterization.
Methods of obtaining vascular access have also
evolved during the past decade. At our institution, cut-
down has virtually disappeared as a means of obtaining
vascular access in neonates. The availability of Doppler-
tipped introducer needles [4] and the transhepatic ap-
proach [5] have essentially eliminated the need for cut-
downs in the neonate. It seems likely that this trend will
continue as fewer fellows have an opportunity to learn
the cutdown approach.
Conclusions
Patterns of care for neonates with severe cardiac disease
have changed substantially during the past decade. Di-
agnostic catheterizations are required much less often
because essential data are usually obtained from echo-
cardiography. Therapeutic catheterization procedures
(e.g., balloon atrial septostomies and balloon dilation for
critical pulmonary and aortic stenosis) are now common-
place in the neonate and have maintained the essential
role of the cardiac catheterization laboratory in neonatal
cardiology.
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